Clinical Trials Logo

Clinical Trial Summary

The goal of this randomised control trial is to learn about the effect of green tea consumption on patients with primary glaucoma. The main questions to answer are: 1. Is there any difference of intraocular pressure (IOP) in patient with primary glaucoma after 1 month, 3 months and 6 months who is consuming green tea compared to patient not consuming green tea? 2. Is there any difference of retina nerve fibre layer in patient with primary glaucoma after 1 month, 3months and 6 months who is consuming green tea compared to patient not consuming green tea? Researchers will compare patients with primary glaucoma who are consuming green tea and normal daily drinking to see if any affect to intraocular pressure and retina nerve fibre layer.


Clinical Trial Description

Glaucoma is a progressive optic neuropathy characterised by loss of retinal ganglion cells (RGCs) with corresponding visual field loss. The current established treatment of glaucoma is by reducing IOP, as one of neuroprotectant factor to prevent further loss RGCs. However, it is not always sufficient to fully prevent disease progression. Oxidative stress is one of biological insult contribute to etiology and progression of glaucoma. Antioxidants represent the first line of defence against oxidative stress and are obtained through the diet and produced internally has shown to be protective towards glaucoma. Green tea is one of the most antioxidant rich drink due to its high content of flavonoids commonly known as catechins. The investigator would like to evaluate the effect of 6 months consumption of green tea on intraocular pressure (IOP) and retinal nerve fibre layer thickness (RNFL) in patients with primary glaucoma. This is a randomised controlled study involving primary glaucoma patients who are attending ophthalmology clinic at Hospital Universiti Sains Malaysia. Evaluation of study sample includes baseline ocular examination, IOP and Optical Coherence Tomography Retinal Nerve Fibre Layer (OCT RNFL). Subjects who fulfil the inclusion and exclusion criteria for the study will be selected. Patients in Group A will consume two cups per day (250ml for each cup) of hot green tea, five days per week for 6 months while other Group B (control group) will not consume green tea. IOP and OCT RNFL measurement will be taken at baseline, first month, 3rd month and 6th month post recruitment of subjects. All patients will be given dietary diary to note down their daily drinks' consumption. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06235827
Study type Interventional
Source Universiti Sains Malaysia
Contact Dr. Siti Sarah Shokri, MBBS
Phone +6017-4588381
Email sarahshokri88@gmail.com
Status Recruiting
Phase N/A
Start date February 1, 2024
Completion date June 2025

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04722861 - Development of the Glaucoma Visual Functioning Questionnaire-40 and Its Psychometric Properties
Enrolling by invitation NCT04323930 - eyeWatch vs. Trabeculectomy RCT (evT) N/A
Recruiting NCT01361841 - Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma N/A
Recruiting NCT06071494 - The Effect Of Tropical Fruits In Patients With Primary Glaucoma N/A
Completed NCT04515030 - Changes of Trace Elements in Aqueous Humor, Blood and Tears and Analysis of Related Factors